Strata Critical Medical, Inc.
Company Stats
- Market Cap
- $452.1M
- as of Sep 30, 2026
- Shares Outstanding
- 88.5M
- Free Float
- 52.4%
Income Statement
- Revenue
- $197.1M
- Operating Income
- -$22.4M
- Net Income
- $41.3M
- EBITDA
- -$14.2M
- Revenue Growth, 3Y
- 10.5%
- FCF Margin, 3Y Avg
- -22.6%
- FCF Margin, Worst Year
- -29.7%
Cash Flow
- Free Cash Flow
- -$58.5M
- FCF Yield
- -12.9%
- Owner FCF Yield
- -16.9%
Balance Sheet
- Cash & Equivalents
- $31.0M
Returns & Capital
- Buyback Yield, 3Y Avg
- 0.0%
- SBC, 3Y Avg
- $16.7M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $197.1M | -$58.5M | -29.7% |
| FY2024 | $146.8M | -$33.4M | -22.7% |
| FY2023 | $225.2M | -$34.5M | -15.3% |
| FY2022 | $146.1M | -$37.9M | -25.9% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 14, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges